145 related articles for article (PubMed ID: 35869413)
1. Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
Rupasinghe D; Choi JY; Yunihastuti E; Kiertiburanakul S; Ross J; Ly PS; Chaiwarith R; Do CD; Chan YJ; Kumarasamy N; Avihingsanon A; Kamarulzaman A; Khusuwan S; Zhang F; Lee MP; Van Nguyen K; Merati TP; Sangle S; Oon Tek N; Tanuma J; Ditangco R; Sim BLH; Pujari S; Jiamsakul A;
J Med Virol; 2022 Nov; 94(11):5451-5464. PubMed ID: 35869413
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and incidence of liver dysfunction and assessment of biomarkers of liver disease in HIV-infected Asian children.
Aurpibul L; Bunupuradah T; Sophan S; Boettiger D; Wati DK; Nguyen LV; Saphonn V; Hansudewechakul R; Chokephaibulkit K; Lumbiganon P; Truong KH; Do VC; Kumarasamy N; Yusoff NK; Razali K; Kurniati N; Fong SM; Nallusamy R; Sohn AH;
Pediatr Infect Dis J; 2015 Jun; 34(6):e153-8. PubMed ID: 25970117
[TBL] [Abstract][Full Text] [Related]
3. Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-Pacific.
Rupasinghe D; Kiertiburanakul S; Kamarulzaman A; Zhang F; Kumarasamy N; Chaiwarith R; Merati TP; Do CD; Khusuwan S; Avihingsanon A; Lee MP; Ly PS; Yunihastuti E; Nguyen KV; Ditangco R; Chan YJ; Pujari S; Ng OT; Choi JY; Sim B; Tanuma J; Sangle S; Ross J; Law M
HIV Med; 2020 Jul; 21(6):397-402. PubMed ID: 31852025
[TBL] [Abstract][Full Text] [Related]
4. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
5. HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.
Bailey H; Nizova N; Martsynovska V; Volokha A; Malyuta R; Cortina-Borja M; Thorne C;
BMC Infect Dis; 2016 Dec; 16(1):755. PubMed ID: 27955711
[TBL] [Abstract][Full Text] [Related]
6. Incident Liver Cirrhosis, Associated Factors, and Cardiovascular Disease Risks Among People Living With HIV: A Longitudinal Study.
Han WM; Ueaphongsukkit T; Chattranukulchai P; Siwamogsatham S; Chaiteerakij R; Sophonphan J; Gatechompol S; Ubolyam S; Phonphithak S; Ruxrungtham K; Tangkijvanich P; Avihingsanon Y; Kerr SJ; Avihingsanon A
J Acquir Immune Defic Syndr; 2021 Apr; 86(4):463-472. PubMed ID: 33273213
[TBL] [Abstract][Full Text] [Related]
7. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
8. Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes.
Maida I; Martin-Carbonero L; Sotgiu G; Vispo E; Barreiro P; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2010 Dec; 17(12):866-71. PubMed ID: 20088891
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
10. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Zhou J; Dore GJ; Zhang F; Lim PL; Chen YM;
J Gastroenterol Hepatol; 2007 Sep; 22(9):1510-8. PubMed ID: 17645479
[TBL] [Abstract][Full Text] [Related]
12. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
[TBL] [Abstract][Full Text] [Related]
13. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.
Mohsen AH; Easterbrook PJ; Taylor C; Portmann B; Kulasegaram R; Murad S; Wiselka M; Norris S
Gut; 2003 Jul; 52(7):1035-40. PubMed ID: 12801963
[TBL] [Abstract][Full Text] [Related]
14. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
[TBL] [Abstract][Full Text] [Related]
15. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
Torti C; Costarelli S; De Silvestri A; Quiros-Roldan E; Lapadula G; Cologni G; Paraninfo G; Castelnuovo F; Puoti M; Carosi G;
Drug Saf; 2007; 30(12):1161-9. PubMed ID: 18035868
[TBL] [Abstract][Full Text] [Related]
16. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
[TBL] [Abstract][Full Text] [Related]
17. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression.
Wang CS; Wang ST; Chang TT; Yao WJ; Chou P
Arch Intern Med; 2002 Apr; 162(7):811-5. PubMed ID: 11926856
[TBL] [Abstract][Full Text] [Related]
18. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
19. HBV, HCV, and HBV/HCV co-infection among HIV-positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome.
Su S; Fairley CK; Sasadeusz J; He J; Wei X; Zeng H; Jing J; Mao L; Chen X; Zhang L
J Med Virol; 2018 Mar; 90(3):518-525. PubMed ID: 29091279
[TBL] [Abstract][Full Text] [Related]
20. Trends in mortality among ART-treated HIV-infected adults in the Asia-Pacific region between 1999 and 2017: results from the TREAT Asia HIV Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) of IeDEA Asia-Pacific.
Jung IY; Rupasinghe D; Woolley I; O'Connor CC; Giles M; Azwa RI; Choi JY;
J Int AIDS Soc; 2019 Jan; 22(1):e25219. PubMed ID: 30615271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
